参考文献/References:
[1]陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析.中国肿瘤,2017,26(1):1-7.
[2]Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal location. Ann Inter Med,1990,113(10):779-788.
[3]Gertler R, Stein HJ, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol,2011,35(10):1512-1522.
[4]Huang Q, Shi J, Feng A, et al. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System Mod Pathol,2011,24(1):138-46.
[5]Sun YS, Han DS, Kong SH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg,2012,255(5):908-915.
[6]Chen W，Zheng R，Baade PD，et al. Cancer statistics in China，2015.CA Cancer J Clin,2016,6(2):115-132.
[7]Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012.CA Cancer J Clin,2015,65(2):87-108.
[8]Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev,2010,19(8):1893-907.
[9]徐惠绵，徐岩.胃癌转移规律研究新进展.中国实用外科杂志,2011,31(8):666-669.
[10]乔鲁冀，徐惠绵，王振宁，等．不同部位胃癌的临床病理学特点及预后对比分析.中国社区医师，2014，30(2):105-107.
[11]Yu X, Hu F, Li C, et al.Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer.Onco Targets Ther,2018,27(11):1037-1044.
[12]赵晨燕,张祥宏,薛丽英，等.河北省食管癌和胃癌高发区居民胃癌发生部位的变化及趋势分析.中华肿瘤杂志,2008,30(11):817-820.
[13]荆晓岳，王建国，周兵，等.近 10 年豫北地区胃癌临床流行病学特征.中国普外基础与临床杂志，2010，17（1）：29-32.
[14]胡晓峰,李磊,等.不同发病部位原发性胃癌患者临床病理特征比较.实用癌症杂志,2016,31(03):449-451.
[15]刘 飞,王雷. 早期近、远端胃癌淋巴结转移差异以及内镜下切除指征的探讨.胃肠病学,2018,23(03):157-160.
[16]周思宁,周小兰.不同部位胃癌组织临床病理特点和生物学行为的差异.世界华人消化杂志,2014,22(18):2607-2611.
[17]Tanner M, Hollmen M, Junttila TT, et al. Amplification of HER-2 in gastric carcinoma: association with topoisomerase Ⅱa gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol,2005,16(2):273-278.
[18]Gulmann C，Grace A，Leader M，et al. Adenomatous polyposis COli Gene，β-Catenin，and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: An immunohtochmical study using tissue microarrays. Appl Immunohistochem Mol Morhpol,2003,11(3):230-237.
[19]Kim MA, Lee HS, Yang HK, et al. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach.Cancer,2005,103(7):1439-1446.
[20]Tang H, Hokita S, Che X, et al. Comparison of p53 expression in proximal and distal gastric cancer: histopathologic correlation and prognostic significance. Ann Surg Oncol,1997,4(6):470-474.
[21]Azarhoush R, Ali Keshtkar A, Amiriani T, et al. Relationship between p53 expression and gastric cancers in Cardia and Antrum. Arch Iranian Med,2008,11(5):502-506.
[22]刘静文,刘红利,张涛,等.胃癌分子分型研究进展.中华临床医师杂志（电子版）,2014,(24):4444-4448.
[23]李启刚,王子卫.近端胃癌的外科手术治疗.医学综述,2016,22(15):2964-2968.
[24]刘俊松,车向明,李铎伟,等.胃上部癌行全胃切除术与近端胃切除术疗效的Meta分析.中华消化外科杂志,2013,12(7):496-499.
[25]Liu Z, Feng F, Guo M, et al. Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore),2017,96(5):e6003.
[26]王晓鹏,郭进,李渊,等.达芬奇机器人联合淋巴示踪在进展期远端胃癌根治术中的应用.中国微创外科杂志,2018,18(3):225-229.
[27]高金辉,李建国,蔡铭智,等.开腹及腹腔镜辅助根治性远端胃切除的对比研究.中国微创外科杂志,2014,14(8):695-697,703.
[28]刘勇,郑志超,赵岩,等.胃上部癌与胃下部癌术前化疗效果比较.山东医药,2014,54(46):45-47.
[29]Murat Sedef A, Taner Sumbul FKA, Ayberk Besen A, et al. Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group. J BUON,2019,24(2):650-655.
[30]陈志新,胡建昆,于永扬,等.近、远端胃癌临床病理特点分析(附428例报告).中国普外基础与临床杂志,2002,9(3):151-153.
[31]Wang X, Liu F, Li Y, et al. Comparison on clinicopathological features, treatments and prognosis between proximal gastric cancer and distal gastric cancer: A national cancer data base analysis. J Cancer，2019,10(14):3145-3153.